George Clinical’s Scientific Leader, Jason Chandler, and members of the project operations and business development team will be attending the 61st ASH Meeting & Exposition in Orlando, Florida December 7–10.
The American Society of Hematology (ASH) annual meeting focuses on malignant and non-malignant hematology. The meeting will provide attendees the opportunity to review thousands of scientific abstracts highlighting updates and trends in hematology. In addition, network and exchange knowledge with leaders in the field and a global community of more than 25,000 hematology professionals from every subspecialty.
Are you looking for answers to questions about an upcoming project? Do you need assistance to ensure your project is a success? George Clinical provides expertise in the design and execution of oncology studies. Please contact us below to arrange a meeting to learn more about our experience in oncology as a leading global CRO.
Dr. Chandler specializes in medical oncology, hematology and blood cancers. He is Director of Research for Hematology Malignancies at West Cancer Center. Dr. Chandler was a co-leader in the efforts to gain FDA approval for the delivery of CAR-T therapy to cancer patients in 2019, paving the way for CAR-T therapies and treatments to be tested across the country. He is interested in research and immunology and committed to providing patients with access to early-stage clinical trials.
Orange County Convention Center
9800 International Dr
Meet with George Clinical! Contact us to schedule a time now.